I

    Inovio Pharmaceuticals Inc (INO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.27
    -0.02 (-1.55%)

    Market Cap: $133.38M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(18/40)
    Avg Surprise
    -14.38%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.20
    Range$-0.20 - $-0.19
    2 analysts
    EPS Revisions
    1
    0
    7d
    2
    0
    30d
    EPS Estimate Drift
    90d ago$-0.24-24.4%
    60d ago$-0.25-26.5%
    30d ago$-0.25-26.5%
    7d ago$-0.23-20.5%
    Current$-0.20
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.04
    Range$0.04 - $0.04
    1 analysts
    Revenue Consensus
    $416670
    Range$-250000 - $2M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.04---
    Sep 26EST
    		-$-0.20---
    Jun 26
    		$-0.07N/A+72.00%Beat+88.5%
    Mar 26
    		$-0.31$-0.33+6.06%Beat+39.2%
    Dec 25
    		$-0.28$-0.34+19.59%Beat+53.8%
    Sep 25
    		$-0.87$-0.48-81.25%Miss+2.2%
    Jun 25
    		$-0.61$-0.62+1.61%Beat+48.7%
    Mar 25
    		$-0.51$-0.74+31.08%Beat+61.1%
    Dec 24
    		$-0.60$-0.83+27.88%Beat+46.4%
    Sep 24
    		$-0.89$-1.13+21.24%Beat+42.9%
    Jun 24
    		$-1.19$-1.10-8.18%Miss+23.7%
    Mar 24
    		$-1.31$-0.99-32.32%Miss+31.8%
    Dec 23
    		$-1.12$-1.27+11.81%Beat-433.3%
    Sep 23
    		$-1.56$-1.50-4.00%Miss+13.3%
    Jun 23
    		$-1.56$-1.72+9.30%Beat+71.7%
    Mar 23
    		$-1.92$-1.80-6.67%Miss+55.6%
    Dec 22
    		$-0.21$-0.17-23.53%Miss+58.0%
    Sep 22
    		$-1.80$-3.27+44.95%Beat+48.3%
    Jun 22
    		$-5.52$-3.52-56.82%Miss-17.9%
    Mar 22
    		$-4.32$-3.93-9.92%Miss-33.3%
    Dec 21
    		$-0.50$-0.32-56.25%Miss-257.1%
    Sep 21
    		$-3.48$-3.62+3.87%Beat-26.1%
    Jun 21
    		$-4.68$-3.06-52.94%Miss+53.0%
    Mar 21
    		$-3.24$-2.34-38.46%Miss-3.8%
    Dec 20
    		$-0.14$-0.22+36.36%Beat+63.2%
    Sep 20
    		$-2.76$-2.30-20.00%Miss+0.0%
    Jun 20
    		$-9.96$-2.02-393.07%Miss-176.7%
    Mar 20
    		$-3.12$-2.85-9.47%Miss+13.3%
    Dec 19
    		$-0.38$-0.24-58.33%Miss-8.6%
    Sep 19
    		$-2.76$-3.07+10.10%Beat+14.8%
    Jun 19
    		$-3.60$-3.46-4.05%Miss-328.6%
    Mar 19
    		$-3.60$-3.06-17.65%Miss+16.7%
    Dec 18
    		$-0.35$-0.28-25.00%Miss-52.2%
    Sep 18
    		$-3.24$-3.54+8.47%Beat+30.8%
    Jun 18
    		$-0.84N/A+64.10%Beat+46.2%
    Mar 18
    		$-4.32$-3.24-33.33%Miss-16.1%
    Dec 17
    		$-0.23$-0.30+23.33%Beat+34.3%
    Sep 17
    		$-4.68$-3.05-53.44%Miss-39.3%
    Jun 17
    		$-1.56$-2.52+38.10%Beat-
    Mar 17
    		$-3.72$-3.75+0.80%Beat-
    Dec 16
    		$-0.35$-0.30-16.67%Miss-
    Sep 16
    		$-3.36$-3.22-4.35%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.83EV/EBITDA-1.09x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-409.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.00xQuick Ratio1.00x
    Trading Statistics
    Beta1.51Avg Volume4.93M
    52-Week High$2.9852-Week Low$0.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.25
    SMA 20$1.03
    SMA 50$1.06
    SMA 200$1.44
    EMA 10$1.22
    EMA 20$1.13
    EMA 50$1.09
    EMA 200$1.38

    MACD

    Line: 0.09Signal: 0.06Hist: 0.03

    ADX

    ADX: 34.7+DI: 35.5-DI: 12.8

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down12.0
    PSAR$1.14

    Bollinger Bands

    Upper Band$1.56
    Lower Band$0.51
    %B Position10133%(Upper)
    Band Width0.73

    RSI (14-Day)

    Neutral
    63.2

    Momentum Oscillators

    Stoch %K85.2
    Stoch %D87.6
    Williams %R-16.1
    ROC (10d)10.4%
    Momentum0.12
    CCI (20d)77.6
    MFI (14d)81.0

    Volatility Measures

    ATR (14d)$0.10(7.8%)
    StdDev (20d)0.26
    Hist Vol109.5%(High)

    Volume Flow

    VWAP$1.30
    OBV45.7M
    AD Line-57.7M
    CMF (20d)0.222

    Volume Metrics

    Avg Vol (20d)4.8M
    Vol Ratio1.2x
    VWMA (20d)$1.05

    Pivot Points

    R3$1.39
    R2$1.35
    R1$1.32
    Pivot Point$1.29
    S1$1.26
    S2$1.22
    S3$1.19

    Advanced Oscillators

    TSI24.24
    Ultimate Osc51.3
    KST325.27

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$-65,343$0$0$65,343$116,994$0$100,762$0$102,650$388,446
    Cost of Revenue$0$0$754,054$0$0$0$775,829$0$0$0$175,227$0
    Gross Profit$0$0$-754,054$0$0$65,343$116,994$0$100,762$0$102,650$388,446
    Operating Expenses$18.62M$21.95M$17.48M$21.21M$23.08M$25.12M$20.49M$27.35M$33.30M$31.48M$27.50M$35.94M
    R&D$10.83M$14.07M$10.26M$13.33M$14.52M$16.09M$12.88M$18.73M$23.09M$20.91M$17.25M$15.50M
    SG&A$7.80M$7.88M$7.22M$7.88M$8.56M$9.02M$7.60M$8.61M$10.21M$10.57M$10.24M$9.93M
    Operating Income$-18,624,522$-21,949,993$-17,476,601$-21,210,455$-23,084,519$-25,050,529$-20,369,561$-27,347,479$-33,196,913$-31,484,969$-27,393,741$-35,553,012
    Interest Income$458,068$-1,585,018$67,294$167,749$2.15M$1.64M$88,519$2.76M$952,244$1.88M$4.46M$1.93M
    Interest Expense$0$0$0$0$0$0$0$0$0$177,833$282,325$313,488
    Income Before Tax$-4,297,838$-19,397,308$3.76M$-43,558,436$-22,816,229$-19,694,215$-17,472,434$-24,585,659$-32,244,669$-29,787,653$-22,714,864$-33,932,718
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,012,458$-19,682,798$3.76M$-45,496,672$-23,519,412$-19,694,697$-19,381,679$-25,165,478$-32,237,098$-30,469,871$-25,003,638$-33,929,864
    EBITDA$-3,998,052$-17,076,888$4.40M$-42,912,659$-24,233,476$-20,594,593$-16,965,375$-26,937,075$-32,838,459$-31,409,890$-28,262,893$-35,759,550
    EBIT$-4,755,906$-17,812,290$3.70M$-43,726,185$-24,962,529$-21,337,657$-17,560,953$-27,347,479$-33,196,913$-31,484,969$-27,393,741$-35,553,012
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INO

    News

    Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

    Shares of Inovio Pharmaceuticals Inc. (INO) rallied 5.93% on Monday, outperforming its competitors despite a mixed trading session for the broader market. The stock closed at $1.25, ending a two-day losing streak. The Dow Jones Industrial Average saw a slight rise, while the NASDAQ Composite Index experienced a decline.

    MarketWatch•8/25/26•
    Neutral

    Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors

    Shares of Inovio Pharmaceuticals Inc. (INO) slipped 2.48% on Friday, closing at $1.18. This underperformance occurred despite a positive trading session for the broader market, with both the NASDAQ Composite Index and the Dow Jones Industrial Average posting gains. This marks the stock's second consecutive day of losses.

    MarketWatch•8/21/26•
    Somewhat-Bearish

    Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors

    Inovio Pharmaceuticals Inc. (INO) shares fell by 6.92% to $1.21 on Thursday, underperforming the broader market. This decline occurred during a poor trading session where the NASDAQ Composite Index and Dow Jones Industrial Average also dropped. The stock's fall ended an eight-day winning streak.

    MarketWatch•8/20/26•
    Bearish

    Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

    Inovio Pharmaceuticals Inc. (INO) shares rose 8.33% to $1.30 on Wednesday, marking its eighth consecutive day of gains. This performance occurred during a favorable trading session where the NASDAQ Composite Index and Dow Jones Industrial Average also saw increases.

    MarketWatch•8/19/26•
    Bullish

    Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

    Inovio Pharmaceuticals Inc. (INO) saw its stock rise by 4.35% to $1.20, marking its seventh consecutive day of gains. This performance stood out on a generally negative trading day where the NASDAQ Composite Index and Dow Jones Industrial Average both experienced declines.

    MarketWatch•8/18/26•
    Bullish

    Frequently Asked Questions About INO

    Does INO pay dividends?
    Inovio Pharmaceuticals Inc (INO) does not currently pay a regular dividend.
    What is INO's market cap?
    Inovio Pharmaceuticals Inc (INO) has a market capitalization of $133.38M with a current stock price of $1.27.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In